People: Boston Scientific Corp (BSX)

Summary

Name	Age	Since	Current Position
Peter Nicholas	71	1999	Chairman of the Board
Michael Mahoney	48	2012	President, Chief Executive Officer, Director
Jeffrey Capello	48	2010	Chief Financial Officer, Executive Vice President
Timothy Pratt	63	2010	Chief Administrative Officer, Executive Vice President, General Counsel, Secretary
Supratim Bose	60	2011	Executive Vice President and President, Asia-Pacific
Keith Dawkins	62	2012	Global Chief Medical Officer, Executive Vice President
Michael Phalen	53	2012	Executive Vice President and President - MedSurg
Kenneth Pucel	46	2012	Executive Vice President - Global Operations, Quality and Technology
Jean Lance	51	2010	Chief Compliance Officer, Senior Vice President
Wendy Carruthers	44	2012	Senior Vice President - Human Resources
Kevin Ballinger		2013	Senior Vice President and President, Interventional Cardiology
Joseph Fitzgerald	49	2011	Senior Vice President and President - Cardiac Rhythm Management
Jeffrey Mirviss	47	2013	Senior Vice President and President - Peripheral Interventions
Maulik Nanavaty	51	2011	Senior Vice President and President - Neuromodulation
John Onuscheck	46	2011	Senior Vice President and President, Europe, the Middle East and Africa
David Pierce	49	2011	Senior Vice President and President - Endoscopy
Karen Prange	49	2012	Senior Vice President and President, Urology & Women's Health
N. Nicholas	73	1994	Director
Katharine Bartlett	66	2009	Independent Director
Bruce Byrnes	64	2009	Independent Director
Nelda Connors	47	2009	Independent Director
Kristina Johnson	55	2011	Independent Director
Ernest Mario	74	2001	Independent Director
Uwe Reinhardt	75	2002	Independent Director
John Sununu	48	2009	Independent Director
Michael Campbell			Vice President - Investor Relation

» Insider Trading

Biographies

Name	Description
Peter Nicholas	Mr. Peter M. Nicholas is Chairman of the Board of Boston Scientific Corporation. He is co-founder, has been Chairman of the Board since 1995. He has been a director since 1979 and served as Chief Executive Officer from 1979 to March 1999 and Co-Chairman of the Board from 1979 to 1995. Prior to joining Boston Scientific, he was corporate director of marketing and general manager of the Medical Products Division at Millipore Corporation, a medical device company, and served in various sales, marketing and general management positions at Eli Lilly and Company. He is a Trustee Emeritus of Duke University. Mr. Nicholas is a Fellow of the National Academy of Arts and Sciences and Vice Chairman of the Trust for that organization. He also serves on several for profit and not-for-profit boards including CEOs for Fundamental Change in Education and the Boys and Girls Club of Boston. After college, Mr. Nicholas served as an officer in the U.S. Navy, resigning his commission as lieutenant in 1966. Mr. Nicholas received a B.A. degree from Duke University, and an M.B.A. degree from The Wharton School of the University of Pennsylvania.
Michael Mahoney	Mr. Michael F. Mahoney is President, Chief Executive Officer, Director of Boston Scientific Inc. He served as President of the Company from October 17, 2011 until assuming his current role. As President of the Company, he was specifically responsible for Cardiac Rhythm Management and Endoscopy (GI and Pulmonary) businesses, as well as certain corporate functions. Prior to joining the Company, he was Worldwide Chairman of the Medical Devices and Diagnostics division of Johnson & Johnson from January 2011 to September 2011 overseeing 50,000 employees and seven franchises. Prior to assuming this position, Mr. Mahoney served as Worldwide Group Chairman of Johnson & Johnson's DePuy franchise, an orthopedics and neurosciences business, from April 2007 through January 2011. From January 2001 through March 2007, Mr. Mahoney served as President and Chief Executive Officer of Global Healthcare Exchange (GHX), a provider of supply chain solutions and services that bring together hospitals, manufacturers, distributors and GPOs. Mr. Mahoney began his career at General Electric Medical Systems, where he spent 12 years, culminating in the role of General Manager of the Healthcare Information Technology business. Mr. Mahoney earned a B.B.A. in Finance from the University of Iowa and a M.B.A. from Wake Forest University.
Jeffrey Capello	Mr. Jeffrey D. Capello is Chief Financial Officer, Executive Vice President of Boston Scientific Corporation, since March 1, 2010. Before then, he served as Senior Vice President and Chief Accounting Officer since June 2008 when he joined Boston Scientific. Prior to joining, he was Senior Vice President and Chief Financial Officer with responsibilities for Business Development at PerkinElmer, Inc. from 2006 to 2008. Prior to that, he was PerkinElmer’s Vice President of Finance, Corporate Controller and Treasurer from 2002 to 2006 and the Vice President, Finance, Corporate Controller, Chief Accounting Officer and Treasurer from 2001 to 2005. From 1991 to June 2001, he held positions including that of partner from 1997 to 2001 at PriceWaterhouseCoopers LLP, a public accounting firm, initially in the United States and later in the Netherlands. Mr. Capello served on the Board of Directors of Sirtis Pharmaceuticals, Inc. including its Audit Committee as both a member and its chair. He holds a B.S. degree in business administration from the University of Vermont and a M.B.A. degree from the Harvard Business School. Mr. Capello is a certified public accountant.
Timothy Pratt	Mr. Timothy A. Pratt is Chief Administrative Officer, Executive Vice President, General Counsel, Secretary of Boston Scientific Corporation. He is responsible for the worldwide management of legal functions, Global Regulatory Affairs, Global Quality, Government Affairs, Human Resources, Health Economics and Reimbursement and Corporate Communications. Mr. Pratt joined Boston Scientific in May 2008 as Executive Vice President, General Counsel and Secretary. Previously, Mr. Pratt worked for the law firm of Shook, Hardy & Bacon. He joined the firm in 1977 and became partner in 1981. He concentrated his practice in the defense of pharmaceutical and medical device litigation and toxic tort cases. Mr. Pratt is a member of the boards of directors and executive committees of the Advanced Medical Technology Association (AdvaMed) and the Federation of Defense and Corporate Counsel (FDCC). He is a member of the board of directors of the New England Legal Foundation. Mr. Pratt earned a B.A. degree at Tarkio College and graduated Order of the Coif from Drake University Law School, where he served one year as editor-in-chief of the Drake Law Review. After graduating, Mr. Pratt was law clerk to Judge Floyd R. Gibson of the U.S. Court of Appeals for the Eighth Circuit.
Supratim Bose	Mr. Supratim Bose is an Executive Vice President and President, Asia-Pacific of Boston Scientific Corporation since December 2011. Before joining the Company, Mr. Bose was Founder and Chief Executive Officer of Singapore-based Bose Consulting Group, which specialized in strategic management consulting services for the healthcare industry, from January 2010 to December 2011. He previously worked for 30 years at Johnson & Johnson where he concluded his tenure as Company Group Chairman of its Medical Devices and Diagnostics business in 2009. Mr. Bose joined Johnson & Johnson Ltd. India in 1981, and held a variety of management positions of increasing responsibility. He earned a B.S. in Chemistry/Physics, a M.S. in Biophysics and a Masters in Management Studies from the Jamnalal Bajaj Institute for Management Studies at the University of Bombay. He has served as a member of the board of directors at Quattro Vascular Pte. Ltd. and Trireme Medical, and as a member of the advisory board at Singapore Management University's Lee Kong Chian School of Business
Keith Dawkins	Dr. Keith D. Dawkins is Global Chief Medical Officer, Executive Vice President of Boston Scientific Corporation, since January 2012. Previously, he was Senior Vice President and Associate Chief Medical Officer of Cardiovascular business from 2008 to 2010. Prior to joining Boston Scientific in 2008, Dr. Dawkins was a practicing interventional cardiologist for 20 years in England. He has earned a series of clinical, research and academic distinctions, including a Post-Doctoral Research Fellowship at Stanford University as a Fulbright Scholar. He served as President of the British Cardiovascular Intervention Society, and held appointments on hospital, regional and national committees, including the National Institute for Health and Clinical Excellence (NICE). He has been an author on 450 academic publications and presentations on a variety of cardiac topics. Dr. Dawkins was educated at London University and Guys Hospital, earning a First Class Honours degree in Pathology. He trained in cardiology at Oxford and at the Brompton & St. George’s Hospital in London.
Michael Phalen	Mr. Michael P. Phalen is an Executive Vice President and President - MedSurg of Boston Scientific Corporation, since January 2012. Prior to this, Mr. Phalen served as Senior Vice President and President of Endoscopy business from 2010 to 2011 and Vice President and President of Endoscopy from 2001 to 2010. Mr. Phalen joined in 1988 and has held a variety of management positions at the Company. Prior to becoming President of the Endoscopy business, he was Vice President, Business Unit Manager for Endoscopic Surgery and Vice President of Global Marketing for Endoscopy. Prior to these appointments, Mr. Phalen held positions as Director of Marketing, Group Product Manager, Regional Sales Manager, Product Manager and Territory Manager. Before joining, he held management positions with MD Technology, Kendall Healthcare and Pennwalt Pharmaceuticals. He earned a B.S. in General Science from Villanova University and an M.B.A. from Fairleigh Dickinson University.
Kenneth Pucel	Mr. Kenneth J. Pucel is an Executive Vice President - Global Operations, Quality and Technology of Boston Scientific Corporation since December 2012. Mr. Pucel was previously Executive Vice President, Global Operations and Technology from January 2011 to December 2012, at which time he assumed responsibility for the Company's Global Quality function. Prior to this, he served as Executive Vice President, Operations from November 2006 to 2011, Senior Vice President, Operations from December 2004 to November 2006, Vice President and General Manager, Operations from September 2002 to December 2004 and Vice President of Operations from June 2001 to September 2002. Prior to that, he held various positions in Cardiovascular Group, including Manufacturing Engineer, Process Development Engineer, Operations Manager, Production Manager and Director of Operations. Mr. Pucel earned a B.S. degree in Mechanical Engineering with a focus on Biomedical Engineering from the University of Minnesota.
Jean Lance	Ms. Jean Fitterer Lance is Chief Compliance Officer, Senior Vice President of Boston Scientific Corporation., since February 10, 2010. Prior to her current role, Ms. Lance served as Vice President and Chief Compliance Officer from late 2009 to February 2010 and as Vice President and General Counsel for Cardiovascular Group from 1996 to 2009. Before joining Boston Scientific in 1996, Ms. Lance was General Counsel and Vice President of Human Resources for Red Line Healthcare Corporation, which was subsequently acquired by McKesson Corporation. Prior to that, she practiced with the national law firm of SNR Denton, formerly known as Sonnenschein Nath & Rosenthal in Chicago, Illinois, where she specialized in corporate law with an emphasis in health law. Ms. Lance served as a member of the Advanced Medical Technology Association's (AdvaMed) Code of Ethics Working Group and was actively engaged in the development of the AdvaMed Code of Ethics on Interactions with health care professionals and the 2008 revisions to the AdvaMed Code of Ethics. Ms. Lance received her B.S. degree with honors in Accounting with French and business administration minors from Minnesota State University – Mankato and a J.D. degree with honors from the University of Minnesota Law School, where she was a member of the Law Review.
Wendy Carruthers	Ms. Wendy Carruthers is Senior Vice President - Human Resources of Boston Scientific Corp., since December 2012. She served as the head of Human Resources on an interim basis from August 2012 to December 2012. In her current role, Ms. Carruthers oversees the Company's human resources activities globally, including Human Resources operations and services, total rewards, talent management, and diversity and inclusion. Prior to her current role, she served as Vice President of Global Talent Management from January 2011 to November 2012, responsible for all aspects of global talent management including the design, development and implementation of global processes and systems to enable managers to identify, attract, leverage and develop people. Ms. Carruthers has been with Boston Scientific for nearly nine years and was previously Vice President of Human Resources for Europe, the Middle East and Africa (EMEA) region, based in Paris, from June 2007 to December 2010; Vice President of Human Resources for Europe from January 2006 to June 2007; and Director of Human Resources for Europe from March 2004 to December 2005. Prior to joining the Company, Ms. Carruthers was Vice President of Human Resources, Europe for global telecommunications company Cable & Wireless. She previously worked in human resources for Diageo, a food and beverage company, and Tesco, a U.K. supermarket chain. Ms. Carruthers holds a B.A. First Class Honors Degree in Modern Languages and is a graduate member of the Chartered Institute of Personnel and Development.
Kevin Ballinger	Mr. Kevin J. Ballinger is Senior Vice President and President, Interventional Cardiology of Boston Scientific Corp., since January 2013. He was President, Interventional Cardiology from July 2011 to January 2013. In his current role, Mr. Ballinger is responsible for developing and bringing to market innovative solutions that diagnose and treat coronary artery disease and cardiac valve disorders. Mr. Ballinger has 17 years of interventional cardiology experience. Prior to serving as President, Interventional Cardiology he held a engineering and general management positions within Interventional Cardiology business unit, including Vice President and General Manager, Group Program Management Cardiology, Rhythm and Vascular from January 2010 to July 2011; Vice President of Research and Development, Peripheral Interventions from September 2008 to January 2010; and Vice President of Program Management, Cardiovascular from September 2006 to September 2008. Mr. Ballinger earned a B.S. in Mechanical Engineering from Michigan Technological University and an M.B.A. from the University of Minnesota.
Joseph Fitzgerald	Mr. Joseph M. Fitzgerald is Senior Vice President and President - Cardiac Rhythm Management of Boston Scientific Corporation, since July 2011 He served as Senior Vice President and President, Endovascular from February 2010 until July 2011. Prior to that, Mr. Fitzgerald was President and General Manager of the Peripheral Interventions business from June 2008 to February 2010 and President of Electrophysiology business from 2005 to 2008. Previously, he held a management positions in Neurovascular and Peripheral Interventions businesses. These included numerous regional and divisional sales management assignments up to and including his roles as Vice President, Global Marketing for the Neurovascular business from January 2001 to July 2005 and Vice President of U.S. Sales for the Neurovascular business from 1997 to January 2001. Prior to joining Boston Scientific in 1990 as a sales representative, Mr. Fitzgerald was with Anheuser Busch, Inc., where he held a variety of sales, marketing and training assignments. Mr. Fitzgerald holds a B.S. in Business from Indiana University and an M.B.A. from Southern Illinois with a concentration in Marketing and Finance.
Jeffrey Mirviss	Mr. Jeffrey B. Mirviss is Senior Vice President and President - Peripheral Interventions of Boston Scientific Corp., since January 2013. He was President, Peripheral Interventions from July 2011 to January 2013. In his current role, Mr. Mirviss is responsible for developing and bringing to market innovative solutions for treating patients with high blood pressure, vascular system blockages and cancer. Mr. Mirviss has 23 years of experience in medical device and pharmaceutical general management, marketing and sales. Since joining the company in 1997, Mr. Mirviss served as Vice President, Group Global Marketing, CRV from July 2009 to July 2011 and Vice President, Global Cardiology Marketing from December 2004 to July 2009. In addition to his positions at Boston Scientific, Mr. Mirviss has worked for companies ranging in size from a pre-revenue venture-backed medical device startup to Dow 30 companies. He holds a Bachelor's degree from the University of Minnesota and an M.B.A. from the University of St. Thomas.
Maulik Nanavaty	Mr. Maulik Nanavaty is Senior Vice President and President - Neuromodulation of Boston Scientific Corporation, since September 2011. Prior to his current role, Mr. Nanavaty was President of Boston Scientific Japan from December 2007 until September 2011. From January 2007 through November 2007, he served as Vice President and General Manager, Interventional Cardiology of Boston Scientific Japan. Mr. Nanavaty joined the Company in 2005 as Vice President, Corporate Strategy of Boston Scientific Japan and served in that capacity through December 2006. Prior to joining the Company, Mr. Nanavaty spent 16 years working in various executive positions at Baxter International, Inc. and Baxter Japan. Mr. Nanavaty is a member of the board of directors for the California Health Institute. Mr. Nanavaty earned a Ph.D. in Pharmaceutical Sciences from the University of Illinois and an M.B.A. from the University of Chicago.
John Onuscheck	Mr. John Michael Onuscheck is Senior Vice President and President, Europe, the Middle East and Africa of Boston Scientific Corporation, since September 2011. Prior to that, he served as the Senior Vice President and President of Neuromodulation business from 2008 until September 2011. Mr. Onuscheck joined Boston Scientific in 2004 with acquisition of Advanced Bionics as the Vice President of Sales and Clinical Services for the Auditory business. He served as Vice President of Sales and Marketing for Pain Management business from September 2004 until February 2010. Mr. Onuscheck earned a B.A. in Business Administration and Psychology from Washington and Jefferson College.
David Pierce	Mr. David A. Pierce is Senior Vice President and President - Endoscopy of Boston Scientific Corporation, since January 2011. Prior to his current role, Mr. Pierce served as Vice President, Marketing for the Company's Endoscopy Division from April 2006 until January 2011. From December 2004 until March 2006, Mr. Pierce was the Group Marketing Director in the Company's Endoscopy Division. He joined Company in 1991 as a Territory Manager before assuming management-level positions of increasing responsibility. Before joining the Company, Mr. Pierce worked as a Senior Sales Representative for Airborne Express and served as a Captain in the United States Army. He earned a B.S. in Business Administration from Norwich University and an M.B.A. from Boston University.
Karen Prange	Ms. Karen Prange is Senior Vice President and President, Urology & Women's Health of Boston Scientific Corp., since June 2012. In this role, she is responsible for developing and bringing to market innovative solutions for the treatment of various urological and gynecological disorders. Prior to her career with Boston Scientific, Ms. Prange spent 17 years with Johnson & Johnson in various medical device businesses, including as Vice President and General Manager, Micrus Endovascular LLC and Codman Neurovascular from September 2010 to June 2012; Vice President and General Manager, Codman Neurovascular from August 2008 to September 2010; and Vice President, Global Marketing for Codman from June 2006 to July 2008. During her tenure with Johnson & Johnson, Ms. Prange was recognized as a results-driven leader with a track record in delivering multiple cycles of business results via strategic change and re-alignment, sales growth, market development, portfolio strategy and global product commercialization. Ms. Prange holds a B.S. in Business Administration with honors from the University of Florida.
N. Nicholas	Mr. N. J. Nicholas is Director of Boston Scientific Corporation, since October 1994. Previously, he served as President of Time, Inc. from September 1986 to May 1990 and Co-Chief Executive Officer of Time Warner, Inc. from May 1990 until February 1992. Mr. Nicholas is a director of Xerox Corporation and Time Warner Cable, Inc. He has served as a member of the President’s Advisory Committee for Trade Policy and Negotiations and the President’s Commission on Environmental Quality. Mr. Nicholas is a Trustee of the Environmental Defense Fund and a member of the Council of Foreign Relations. He is a member of the board of directors of the Nicholas Institute at Duke University. Mr. Nicholas received an A.B. degree from Princeton University and an M.B.A. degree from Harvard Business School.
Katharine Bartlett	Ms. Katharine T. Bartlett is an Independent Director of Boston Scientific Corporation, since August 1, 2009. Ms. Bartlett has been a full-time member of the Duke University School of Law since 1983 and is the A. Kenneth Pye Professor of Law at the Duke University School of Law, where she served as Dean from 2000 to 2007. Following her deanship, she was a visiting fellow at New York University School of Law during the Fall 2007 semester and Columbia University School of Law during the Spring 2008 semester. She is a member of the executive committee of the Association of American Law Schools. She earned a B.A. degree from Wheaton College, magna cum laude, Phi Beta Kappa; an M.A. degree from Harvard University; and a J.D. degree from the Boalt Hall School of Law at the University of California, Berkeley, where she served as an editor of the Law Review.
Bruce Byrnes	Mr. Bruce L. Byrnes is an Independent Director of Boston Scientific Corporation, since August 1, 2009. Mr. Byrnes is a retired Vice Chairman of the Board for The Procter and Gamble Company. During his 38-year career with Procter and Gamble, Mr. Byrnes served as Vice Chairman of the Board and as President for several global divisions, including health care. Mr. Byrnes is a director of Brown-Forman Corporation, Cincinnati Bell, Inc. and Diebold, Incorporated. He has also served as a trustee of the Cincinnati Art Museum. He holds a B.A. degree from Princeton University. Among his other qualifications, Mr. Byrnes brings Board executive experience including his service as an executive of a multinational public company, along with his experience in brand management, business strategy, financial reporting, risk management and sales and marketing.
Nelda Connors	Ms. Nelda J. Connors is an Independent Director of Boston Scientific Corporation, since December 15, 2009. Ms. Connors is the President and Chief Executive Officer of Atkore International. Atkore, formerly the Electrical and Metal Products division of Tyco International, became a privately-held company in December 2010. Ms. Connors served as President of this Tyco division from 2008 through 2010. Prior to joining Tyco, she served as Vice President at Eaton Corporation from 2007 to 2008 and held several positions in operations and general management from 2002 to 2007. Prior to joining Eaton, Ms. Connors was employed in a number of executive and management capacities with Ford Motor Company from 1997 to 2002, as well as at Chrysler and Mogami Denki, a Toyota supplier, prior to that. She began her career as an engineer with Monsanto Corporation. Ms. Connors is a member of the founders board of Governors State University and trustee for Peggy Notebaert Nature Museum. She currently serves on the Board of Atkore International, Inc. and previously served as an advisory board member to Rock Gate Partners, a boutique private equity and advisory firm. Ms. Connors holds B.S. and M.S. degrees in mechanical engineering from the University of Dayton.
Kristina Johnson	Dr. Kristina M. Johnson is an Independent Director of Boston Scientific Corporation, since January 1, 2011. She previously served as a director from April 2006 to 2009. From March 2009 to October 2010, Dr. Johnson served as Under Secretary of Energy at the U.S. Department of Energy. Prior to this, Dr. Johnson was Provost and Senior Vice President of Academic Affairs at The Johns Hopkins University from 2007 to 2009 and Dean of the Pratt School of Engineering at Duke University from 1999 to 2007. Previously, she served as a professor in the Electrical and Computer Engineering Department, University of Colorado and as director of the National Science Foundation Engineering Research Center for Optoelectronics Computing Systems at the University of Colorado, Boulder. Dr. Johnson rejoined the board of directors of AES Corporation where she had previously served from 2004 until 2009. She served on the boards of directors of Nortel Networks from 2006 until 2009 and Minerals Technologies from 2000 until 2009. Dr. Johnson was a Fulbright Faculty Scholar in the Department of Electrical Engineering at the University of Edinburgh, Scotland and a NATO Post-Doctoral Fellow at Trinity College, Dublin, Ireland. Dr. Johnson received B.S., M.S. and Ph.D. degrees in electrical engineering from Stanford University.
Ernest Mario	Dr. Ernest Mario is an Independent Director of Boston Scientific Corporation, since October 30, 2001. Since August 2007, Dr. Mario has served as the Chairman and Chief Executive Officer of Capnia, Inc., a privately-held pharmaceutical company. From April 2003 to August 2007, Dr. Mario was Chairman of Reliant Pharmaceuticals and also served as its Chief Executive Officer from 2003 to 2006. Prior to joining Reliant, he was the Chairman and Chief Executive Officer of IntraBiotics Pharmaceuticals, Inc., a biopharmaceutical company, and its predecessor, Apothogen, Inc. from January 2002 to April 2003. From 1993 to 1997, Dr. Mario served as Chairman and Chief Executive Officer of ALZA Corporation, a research based pharmaceutical company with drug delivery technologies, and Co-Chairman and Chief Executive Officer from 1997 to 2001. Prior to joining ALZA, Dr. Mario served as the Chief Executive Officer of Glaxo Holdings plc from 1989 to 1993 and as Deputy Chairman and Chief Executive from 1992 to March 1993. Dr. Mario presently serves on the boards of directors of Maxygen, Inc., Pharmaceutical Product Development, Inc. and Celgene Corporation. He previously served as a member of the board of directors of Avid Pharmaceuticals, Inc. and was a Trustee of Duke University from 1988 to 2007 and Chairman of the Board of the Duke University Health System which he chaired from its inception in 1996 until he retired in 2007. He is a past Chairman of the American Foundation for Pharmaceutical Education and serves as an advisor to the pharmacy schools at the University of Maryland, the University of Rhode Island and The Ernest Mario School of Pharmacy at Rutgers University. Dr. Mario holds a B.S. in Pharmacy from Rutgers University, and a M.S. and a Ph.D. in Physical Sciences from the University of Rhode Island. He also holds honorary doctorates from Rutgers University and the University of Rhode Island.
Uwe Reinhardt	Dr. Uwe E. Reinhardt is an Independent Director of Boston Scientific Corporation, since May 7, 2002. Dr. Reinhardt is the James Madison Professor of Political Economy and Professor of Economics and Public Affairs at Princeton University, where he has taught since 1968. Dr. Reinhardt is a senior associate of the University of Cambridge, England and serves as a Trustee of the Duke University Health System, H&Q Healthcare Investors, H&Q Life Sciences Investors and Hambrecht & Quist Capital Management LLC. He is the Commissioner of the Kaiser Family Foundation Commission on Medicaid and the Uninsured and a member of the boards of directors of Amerigroup Corporation and Legacy Hospital Partners, Inc. During 2007 through 2009, he served as President of the International Health Economics Association. In October 2009, Dr. Reinhardt was awarded by Germany’s President the Bundesverdienstkreuz (German Federal Merit Medal) for his work in international health economics and policy. Dr. Reinhardt received a Bachelor of Commerce degree from the University of Saskatchewan, Canada and a Ph.D. in economics from Yale University.
John Sununu	Senator John E. Sununu is an Independent Director of Boston Scientific Corporation, since April 1, 2009. From 2003 to 2009, Senator Sununu served as a U.S. Senator from New Hampshire. He was a member of the Committees on Banking, Commerce, Finance and Foreign Relations, and he was appointed the Congressional Representative to the United Nations General Assembly. Before his election to the Senate, Senator Sununu served three terms as a Member of the U.S. House of Representatives from New Hampshire’s 1st District from 1996 to 2002. He was Vice Chairman of the Budget Committee and a member of the Appropriations Committee. During his 12 years in Congress, he drafted and helped pass several important pieces of legislation, including the Internet Tax Freedom Act, the Survivors Benefit Act and the New England Wilderness Act. Prior to serving in Congress, Senator Sununu served as Chief Financial Officer for Teletrol Systems, a manufacturer of building control systems. He serves on the Board of Managers for ConvergEx Holdings LLC and the Board of Directors of Time Warner Cable, Inc. He holds B.S. and M.S. degrees in Mechanical Engineering from the Massachusetts Institute of Technology and an M.B.A. from Harvard Business School.
Michael Campbell

Basic Compensation

Name	Fiscal Year Total
Peter Nicholas	1,265,810
Michael Mahoney	10,783,800
Jeffrey Capello	3,176,690
Timothy Pratt	2,584,840
Supratim Bose	2,331,740
Keith Dawkins	--
Michael Phalen	--
Kenneth Pucel	2,362,180
Jean Lance	--
Wendy Carruthers	--
Kevin Ballinger	--
Joseph Fitzgerald	--
Jeffrey Mirviss	--
Maulik Nanavaty	--
John Onuscheck	--
David Pierce	--
Karen Prange	--
N. Nicholas	--
Katharine Bartlett	--
Bruce Byrnes	--
Nelda Connors	--
Kristina Johnson	--
Ernest Mario	--
Uwe Reinhardt	--
John Sununu	--
Michael Campbell	--

As Of 30 Dec 2012

Options Compensation

Name	Options	Value
Peter Nicholas	1,910,250	16,940,650
Michael Mahoney	0	0
Jeffrey Capello	0	0
Timothy Pratt	0	0
Supratim Bose	0	0
Keith Dawkins	0	0
Michael Phalen	0	0
Kenneth Pucel	0	0
Jean Lance	0	0
Wendy Carruthers	0	0
Kevin Ballinger	0	0
Joseph Fitzgerald	0	0
Jeffrey Mirviss	0	0
Maulik Nanavaty	0	0
John Onuscheck	0	0
David Pierce	0	0
Karen Prange	0	0
N. Nicholas	0	0
Katharine Bartlett	0	0
Bruce Byrnes	0	0
Nelda Connors	0	0
Kristina Johnson	0	0
Ernest Mario	0	0
Uwe Reinhardt	0	0
John Sununu	0	0
Michael Campbell	0	0

Insider Trading

Name	Shares Traded	Price
MIRVISS JEFFREY B	2,000	$9.36
MIRVISS JEFFREY B	2,071	$9.38
MIRVISS JEFFREY B	6,870	$9.36
CARRUTHERS WENDY	3,535	$9.14
CARRUTHERS WENDY	200	$9.17
CARRUTHERS WENDY	21,266	$9.16
CONNORS NELDA J	24,116	$9.17
CAPELLO JEFFREY D	7,235	$0.00
CAPELLO JEFFREY D	2,359	$8.45
REINHARDT UWE E	22,756	$0.00
NICHOLAS PETER M	22,756	$0.00
BARTLETT KATHARINE T	22,756	$0.00
BYRNES BRUCE L	22,756	$0.00
MARIO ERNEST B	30,000	$7.76
PRATT TIMOTHY A	14,746	$0.00
PRATT TIMOTHY A	4,808	$7.49
NANAVATY MAULIK	2,269	$0.00
PIERCE DAVID A	1,139	$7.39
DAWKINS KEITH D	4,888	$0.00
ONUSCHECK JOHN MICHAEL	5,237	$0.00
PUCEL KENNETH J	3,520	$7.39
BALLINGER KEVIN J	5,586	$0.00
CAPELLO JEFFREY D	3,415	$7.39
ONUSCHECK JOHN MICHAEL	2,396	$7.39
DAWKINS KEITH D	1,594	$7.39

» Full list on Insider Trading

People: Boston Scientific Corp (BSX)

Related Topics:

Summary

Biographies

Basic Compensation

Options Compensation

Related Topics: